Award
National Cancer Institute 5K00CA264404-05
Toward safe, systemic immunotherapies for treatment of metastatic disease: Developing dendritic cell-biased immunomodulators with precise control over magnitude and timing of immune stimulation
Recipient
Yale University
Award Amount
$109,061.00
Ceiling
$109,061.00
Awarded
July 16, 2025
Identifier
5K00CA264404-05
Research project by National Cancer Institute to develop dendritic cell-biased immunomodulators for metastatic disease immunotherapy, awarded $109,061.
Description
This is a research project funded by the National Cancer Institute, focusing on immunotherapy for metastatic disease, with a total award amount of $109,061. The project involves developing dendritic cell-biased immunomodulators with precise control over immune stimulation.